Transferrin receptor 2 is frequently expressed in human cancer cell lines.
Different proteins ensure the fine control of iron metabolism at the level of various tissues. Among these proteins, it was discovered a second transferrin receptor (TfR2), that seems to play a key role in the regulation of iron homeostasis. Its mutations are responsible for type 3 hemochromatosis (Type 3 HH). Although TfR2 expression in normal tissues was restricted at the level of liver and intestine, we observed that TfR2 was frequently expressed in tumor cell lines. Particularly frequent was its expression in ovarian cancer, colon cancer and glioblastoma cell lines; less frequent was its expression in leukemic and melanoma cell lines. Interestingly, in these tumor cell lines, TfR2 expression was inversely related to that of receptor 1 for transferrin (TfR1). Experiments of in vitro iron loading or iron deprivation provided evidence that TfR2 is modulated in cancer cell lines according to cellular iron levels following two different mechanisms: (i) in some cells, iron loading caused a downmodulation of total TfR2 levels; (ii) in other cell types, iron loading caused a downmodulation of membrane-bound TfR2, without affecting the levels of total cellular TfR2 content. Iron deprivation caused in both conditions an opposite effect compared to iron loading. These observations suggest that TfR2 expression may be altered in human cancers and warrant further studies in primary tumors. Furthermore, our studies indicate that, at least in tumor cells, TfR2 expression is modulated by iron through different biochemical mechanisms, whose molecular basis remains to be determined.
Calzolari
Alessia
A
Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Oliviero
Isabella
I
Deaglio
Silvia
S
Mariani
Gualtiero
G
Biffoni
Mauro
M
Sposi
Nadia Maria
NM
Malavasi
Fabio
F
Peschle
Cesare
C
Testa
Ugo
U
D015703:Antigens, CD / Q000096:biosynthesis / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D018922:HL-60 Cells; D006432:Hemochromatosis / Q000235:genetics / Q000378:metabolism; D006706:Homeostasis / Q000235:genetics; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D007501:Iron / Q000378:metabolism*; D020014:K562 Cells; D007938:Leukemia / Q000235:genetics / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008545:Melanoma / Q000235:genetics / Q000378:metabolism*; D009154:Mutation; D011990:Receptors, Transferrin / Q000096:biosynthesis* / Q000235:genetics; D020298:U937 Cells
D015703:Antigens, CD; C068126:CD71 antigen; D011990:Receptors, Transferrin; C503640:TFR2 protein, human; D007501:Iron